Mesa Laboratories Director Buys 3,500 Shares

Shiraz Shabanali Ladiwala increases stake in the medical instruments company

Mar. 11, 2026 at 11:39am

Got story updates? Submit your updates here. ›

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director Shiraz Shabanali Ladiwala bought 3,500 shares of the company's stock on Tuesday, March 10th. The shares were acquired at an average cost of $72.23 per share, with a total value of $252,805.00. Following the purchase, Ladiwala now owns 8,523 shares in the company, valued at $615,616.29.

Why it matters

Insider buying can be a positive signal for investors, as it suggests the director believes the company's stock is undervalued. Mesa Laboratories is a medical instruments supplier that provides critical process monitoring, testing, and calibration products to healthcare, pharmaceutical, and other industries.

The details

Ladiwala's purchase increased his stake in Mesa Laboratories by 69.68%. The company's stock has traded between $55.45 and $131.20 over the past 52 weeks, and currently has a market cap of $404.23 million. Mesa Laboratories reported strong quarterly earnings in February, beating analyst estimates.

  • The transaction took place on Tuesday, March 10th, 2026.

The players

Shiraz Shabanali Ladiwala

A director of Mesa Laboratories, Inc.

Mesa Laboratories, Inc.

A global provider of instrumentation products for critical process monitoring, testing and calibration in the healthcare, pharmaceutical, food and beverage, energy and industrial sectors.

Got photos? Submit your photos here. ›

The takeaway

Insider buying by a director can be a positive signal for investors, as it suggests the director believes the company's stock is undervalued. Mesa Laboratories' strong quarterly earnings and diversified customer base in regulated industries make it an interesting investment opportunity for those monitoring insider transactions.